(Q35675838)

9 August 2017

1 reference

title

Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations (English)

1 reference

9 August 2017

1

Olufunmilayo I Olopade

1 reference

9 August 2017

Grazia Artioli

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

10 Suppl 1

1 reference

9 August 2017

page(s)

S5-9

1 reference

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2004.101S3.X

10.1111/J.1524-4741.2004.101S3.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference